OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
Taku Fujimura, Ryo Amagai, Yumi Kambayashi, et al.
Pharmaceutics (2021) Vol. 13, Iss. 2, pp. 200-200
Open Access | Times Cited: 13
Showing 13 citing articles:
Impact of Hyaluronic Acid on the Cutaneous T-Cell Lymphoma Microenvironment: A Novel Anti-Tumor Mechanism of Bexarotene
Tetsuya Ikawa, Emi Yamazaki, Ryo Amagai, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 324-324
Open Access
Tetsuya Ikawa, Emi Yamazaki, Ryo Amagai, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 324-324
Open Access
Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series
Signe Hedebo, Martin Bjerregård Pedersen, Lise M. Lindahl, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv40952-adv40952
Open Access
Signe Hedebo, Martin Bjerregård Pedersen, Lise M. Lindahl, et al.
Acta Dermato Venereologica (2025) Vol. 105, pp. adv40952-adv40952
Open Access
Stromal Factors as a Target for Immunotherapy in Melanoma and Non-Melanoma Skin Cancers
Taku Fujimura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4044-4044
Open Access | Times Cited: 13
Taku Fujimura
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 4044-4044
Open Access | Times Cited: 13
Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides
Taku Fujimura, Kentaro Ohuchi, Tetsuya Ikawa, et al.
Hematological Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1
Taku Fujimura, Kentaro Ohuchi, Tetsuya Ikawa, et al.
Hematological Oncology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 1
Inhibition of Integrin αVβ3 Signaling Improves the Antineoplastic Effect of Bexarotene in Cutaneous T-Cell Lymphoma
Florencia Cayrol, María V. Revuelta, Mercedes Debernardi, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 9, pp. 1485-1496
Open Access | Times Cited: 5
Florencia Cayrol, María V. Revuelta, Mercedes Debernardi, et al.
Molecular Cancer Therapeutics (2022) Vol. 21, Iss. 9, pp. 1485-1496
Open Access | Times Cited: 5
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real‐world case series
Ryo Amagai, Yumi Kambayashi, Kentaro Ohuchi, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Open Access | Times Cited: 5
Ryo Amagai, Yumi Kambayashi, Kentaro Ohuchi, et al.
Dermatologic Therapy (2022) Vol. 35, Iss. 11
Open Access | Times Cited: 5
CD25 expression could be a prognostic marker of bexarotene monotherapy for cutaneous T‐cell lymphomas
Jun Yamamoto, Kentaro Ohuchi, Ryo Amagai, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Jun Yamamoto, Kentaro Ohuchi, Ryo Amagai, et al.
Skin Health and Disease (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 2
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
Mayuko Amagai, Sadanori Furudate, Kentaro Ohuchi, et al.
Case Reports in Oncology (2022) Vol. 15, Iss. 2, pp. 726-731
Open Access | Times Cited: 3
Mayuko Amagai, Sadanori Furudate, Kentaro Ohuchi, et al.
Case Reports in Oncology (2022) Vol. 15, Iss. 2, pp. 726-731
Open Access | Times Cited: 3
Diagnosis dan Tata Laksana Eritroderma
Nurrul Izza Misturiansyah, Umi Miranti, Ayu Lilyana Nuridah, et al.
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 6, pp. 311-315
Open Access
Nurrul Izza Misturiansyah, Umi Miranti, Ayu Lilyana Nuridah, et al.
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 6, pp. 311-315
Open Access
A Retrospective Cohort Study to Determine Real-World Treatment Patterns in Patients with Sézary Syndrome in the United States
Robert Ristuccia, Yang Zhao, Chunlan Chang, et al.
Oncology and Therapy (2024)
Open Access
Robert Ristuccia, Yang Zhao, Chunlan Chang, et al.
Oncology and Therapy (2024)
Open Access
Quantitative Analysis of Immune-Reactive Cells among Leukocytes Is Useful for the Diagnosis of Drug Eruptions Caused by Bexarotene
Hiromu Chiba, Yumi Kambayashi, Kentaro Ohuchi, et al.
Case Reports in Oncology (2022) Vol. 15, Iss. 1, pp. 40-45
Open Access | Times Cited: 1
Hiromu Chiba, Yumi Kambayashi, Kentaro Ohuchi, et al.
Case Reports in Oncology (2022) Vol. 15, Iss. 1, pp. 40-45
Open Access | Times Cited: 1
RXRα agonist bexarotene attenuates radiation-induced skin injury by relieving oxidative stress
Sheng Jiang, Weichao Cai, Jianhui Chen, et al.
Radiation Medicine and Protection (2022) Vol. 3, Iss. 2, pp. 56-63
Open Access
Sheng Jiang, Weichao Cai, Jianhui Chen, et al.
Radiation Medicine and Protection (2022) Vol. 3, Iss. 2, pp. 56-63
Open Access
